These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34499221)

  • 1. p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.
    Diesing K; Ribback S; Winter S; Gellert M; Oster AM; Stühler V; Gläser E; Adler F; Hartwig C; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3565-3576. PubMed ID: 34499221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma.
    Razafinjatovo CF; Stiehl D; Deininger E; Rechsteiner M; Moch H; Schraml P
    Oncotarget; 2017 Feb; 8(6):10199-10212. PubMed ID: 28052007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
    Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
    Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis.
    He D; Yu Z; Liu S; Dai H; Xu Q; Li F
    Med Sci Monit; 2018 Nov; 24():8391-8400. PubMed ID: 30459299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Identification of Zinc-Finger Protein 433 as a Possible Prognostic Biomarker for Clear-Cell Renal Cell Carcinoma.
    Heyliger SO; Soliman KFA; Saulsbury MD; Reams RR
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
    Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
    Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-34a-5p can rescue disruption of the p53-DAPK axis to suppress progression of clear cell renal cell carcinoma.
    Jing ZF; Bi JB; Li Z; Liu X; Li J; Zhu Y; Zhang XT; Zhang Z; Li Z; Kong CZ
    Mol Oncol; 2019 Oct; 13(10):2079-2097. PubMed ID: 31294899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma.
    Sekino Y; Han X; Babasaki T; Miyamoto S; Kitano H; Kobayashi G; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Oncology; 2020; 98(10):689-698. PubMed ID: 32585672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2.
    Kim SY; Keillor JW
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
    Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma.
    Simoni M; Menegazzi C; Fracassi C; Biffi CC; Genova F; Tenace NP; Lucianò R; Raimondi A; Tacchetti C; Brugarolas J; Mazza D; Bernardi R
    EMBO Mol Med; 2024 Jun; 16(6):1324-1351. PubMed ID: 38730056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
    Li P; Liu J; Li J; Liu P
    Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knocking down NSUN5 inhibits the development of clear cell renal cell carcinoma by inhibiting the p53 pathway.
    Li L; Li M; Zheng J; Li Z; Chen X
    Aging (Albany NY); 2023 Jun; 15(11):4757-4773. PubMed ID: 37263638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-MYB-p53-related relevant regulator for the progression of clear cell renal cell carcinoma.
    Nientiedt M; Müller K; Nitschke K; Erben P; Steidler A; Porubsky S; Popovic ZV; Waldbillig F; Mühlbauer J; Kriegmair MC
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):129-138. PubMed ID: 32951068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53.
    Shi ZG; Li SQ; Li ZJ; Zhu XJ; Xu P; Liu G
    Clin Transl Oncol; 2015 Jan; 17(1):65-73. PubMed ID: 25028191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.